16 results in Exploration of Targeted Anti-tumor Therapy
Latest
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Original Article
Analysis of the benefit of anti-PD-1 monotherapy according to NGS-diagnosed genetic alterations in patients with non-small cell lung cancer
Hortense De Saint Basile ... Elizabeth Fabre
Published: December 18, 2024 Explor Target Antitumor Ther. 2024;5:1435–1449
This article belongs to the special issue Immune Checkpoint Therapy and Biomarkers in Cancer
Open Access
Review
Nigerian medicinal plants with potential anticancer activity—a review
Mansurah A. Abdulazeez ... Amos A. Fatokun
Published: December 09, 2024 Explor Target Antitumor Ther. 2024;5:1393–1434
Open Access
Review
Curative immunotherapy-based strategies for non-metastatic non-small cell lung cancer
Justin J. Kuhlman ... Yujie Zhao
Published: December 06, 2024 Explor Target Antitumor Ther. 2024;5:1373–1392
This article belongs to the special issue Immunotherapy Strategies for Non-small Cell Lung Cancer
Open Access
Perspective
The promises and perils of circulating tumor DNA for monitoring immunotherapy response in non-small cell lung cancer
Brandon Joseph Hebert, James Bradley
Published: November 26, 2024 Explor Target Antitumor Ther. 2024;5:1365–1372
This article belongs to the special issue Immunotherapy Strategies for Non-small Cell Lung Cancer
Open Access
Review
Targeted therapies and molecular targets in the therapeutic landscape of advanced urothelial carcinoma: state of the art and future perspectives
Irene Testi ... Ursula Vogl
Published: November 21, 2024 Explor Target Antitumor Ther. 2024;5:1326–1364
This article belongs to the special issue Emerging Molecular Targets and Therapies of Genitourinary Tumors
Open Access
Editorial
Predictive and prognostic biomarkers in cancer: towards the precision medicine era
Stefano Marletta ... Luca Falzone
Published: November 20, 2024 Explor Target Antitumor Ther. 2024;5:1321–1325
This article belongs to the special issue Predictive and Prognostic Biomarkers in Cancer: Towards the Precision Medicine Era
Open Access
Review
Addressing the unmet need in NSCLC progression with advances in second-line therapeutics
Kinsley Wang ... Robert Hsu
Published: November 1, 2024 Explor Target Antitumor Ther. 2024;5:1297–1320
This article belongs to the special issue Immunotherapy Strategies for Non-small Cell Lung Cancer
Open Access
Short Communication
Preliminary evaluation of FAPI-04-PET/CT for differentiating recurrence and post-treatment changes in high-grade gliomas
Indraja D. Dev ... Archi Agrawal
Published: October 31, 2024 Explor Target Antitumor Ther. 2024;5:1289–1296
Open Access
Original Article
Predictive markers of response to immune checkpoint inhibitor rechallenge in metastatic non-small cell lung cancer
Aram A. Musaelyan ... Sergey V. Orlov
Published: October 18, 2024 Explor Target Antitumor Ther. 2024;5:1271–1288
This article belongs to the special issue Immunotherapy Strategies for Non-small Cell Lung Cancer
Open Access
Case Report
Upper tract urothelial cancer (UTUC) genomic profiling and correlation regarding benefit of platinum-based chemotherapy
Min Woo Hwang ... Jeanny B. Aragon-Ching
Published: October 17, 2024 Explor Target Antitumor Ther. 2024;5:1261–1270
This article belongs to the special issue Emerging Molecular Targets and Therapies of Genitourinary Tumors
Open Access
Review
Evidence for the evolving role of neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancer
Thomas Hansen ... Udit Nindra
Published: September 29, 2024 Explor Target Antitumor Ther. 2024;5:1247–1260
This article belongs to the special issue Immunotherapy Strategies for Non-small Cell Lung Cancer
Open Access
Review
Exploring the therapeutic potential of lipid-based nanoparticles in the management of oral squamous cell carcinoma
Anis Ahmad Chaudhary ... Md. Rizwanullah
Published: September 29, 2024 Explor Target Antitumor Ther. 2024;5:1223–1246
Open Access
Review
Blood-based circulating biomarkers for prediction of immune-checkpoint inhibitors efficacy in renal cell carcinoma
Loubna Omri ... Lucía Carril-Ajuria
Published: September 20, 2024 Explor Target Antitumor Ther. 2024;5:1199–1222
This article belongs to the special issue Immune Checkpoint Therapy and Biomarkers in Cancer
Open Access
Systematic Review
Diagnostic and prognostic role of NLR in testicular cancer
Shirin Sarejloo ... Brandon Lucke-Wold
Published: September 19, 2024 Explor Target Antitumor Ther. 2024;5:1177–1198
This article belongs to the special issue Emerging Molecular Targets and Therapies of Genitourinary Tumors
Open Access
Original Article
Diagnostic utility of prostate health index density prior to MRI-ultrasound fusion targeted biopsy
Benjamin H. Press ... Preston C. Sprenkle
Published: September 13, 2024 Explor Target Antitumor Ther. 2024;5:1168–1176
Open Access
Review
GPCRs as targets for flavonoids in cancer cells: new options for intervention
Katrin Sak
Published: August 30, 2024 Explor Target Antitumor Ther. 2024;5:1155–1167
